These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 16571086

  • 21. Association of polymorphic variants of IL-1β and IL-1RN genes in the development of Graves' disease in Kashmiri population (North India).
    Shehjar F, Afroze D, Misgar RA, Malik SA, Laway BA.
    Hum Immunol; 2018 Apr; 79(4):228-232. PubMed ID: 29454070
    [Abstract] [Full Text] [Related]

  • 22. L-selectin gene polymorphisms in Graves' disease.
    Chen HY, Cui B, Wang S, Zhao ZF, Sun H, Zhao YJ, Li XY, Ning G.
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):145-51. PubMed ID: 17465998
    [Abstract] [Full Text] [Related]

  • 23. Association between interleukin 21 and Graves' disease.
    Jia HY, Zhang ZG, Gu XJ, Guo T, Cui B, Ning G, Zhao YJ.
    Genet Mol Res; 2011 Oct 31; 10(4):3338-46. PubMed ID: 22057994
    [Abstract] [Full Text] [Related]

  • 24. TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy.
    Bufalo NE, Dos Santos RB, Marcello MA, Piai RP, Secolin R, Romaldini JH, Ward LS.
    J Endocrinol Invest; 2015 May 31; 38(5):555-61. PubMed ID: 25543543
    [Abstract] [Full Text] [Related]

  • 25. Poly (ADP-ribose) polymerase-1 (PARP-1) in Chinese patients with Graves' disease and Graves' ophthalmopathy.
    Wu T, Tang DR, Zhao L, Sun FY.
    Can J Physiol Pharmacol; 2018 Jun 31; 96(6):556-561. PubMed ID: 28177666
    [Abstract] [Full Text] [Related]

  • 26. Interleukin-1-beta gene, but not the interleukin-1 receptor antagonist gene, is associated with Graves' disease.
    Chen RH, Chen WC, Chang CT, Tsai CH, Tsai FJ.
    J Clin Lab Anal; 2005 Jun 31; 19(4):133-8. PubMed ID: 16025481
    [Abstract] [Full Text] [Related]

  • 27. Genetic association between IL-17F gene polymorphisms and the pathogenesis of Graves' Disease in the Han Chinese population.
    Guo T, Huo Y, Zhu W, Xu F, Liu C, Liu N, Cao M, Cui B, Ning G.
    Gene; 2013 Jan 10; 512(2):300-4. PubMed ID: 23111159
    [Abstract] [Full Text] [Related]

  • 28. Polymorphisms of endothelin 1 (G5665T and T-1370G) and endothelin receptor type A (C+70G and G-231A) in Graves' disease.
    Aydın AF, Develi-İş S, Doğru-Abbasoğlu S, Vural P, Ozderya A, Karadağ B, Uysal M.
    Int Immunopharmacol; 2014 Jan 10; 18(1):198-202. PubMed ID: 24291390
    [Abstract] [Full Text] [Related]

  • 29. IL-18 gene polymorphism confers susceptibility to the development of anti-GAD65 antibody in Graves' disease.
    Hiromatsu Y, Mukai T, Kaku H, Miyake I, Ichimura M, Fukutani T, Nakayama H, Takata K, Imamura Y, Shoji S, Yamada K, Koda Y, Bednarczuk T.
    Diabet Med; 2006 Feb 10; 23(2):211-5. PubMed ID: 16433722
    [Abstract] [Full Text] [Related]

  • 30. Association of TLR7 and TSHR copy number variation with Graves' disease and Graves' ophthalmopathy in Chinese population in Taiwan.
    Liao WL, Wan L, Wang TY, Chen CC, Tse SS, Lu CH, Tsai FJ.
    BMC Ophthalmol; 2014 Feb 11; 14():15. PubMed ID: 24517461
    [Abstract] [Full Text] [Related]

  • 31. Foxp3 gene polymorphisms and haplotypes associate with susceptibility of Graves' disease in Chinese Han population.
    Zheng L, Wang X, Xu L, Wang N, Cai P, Liang T, Hu L.
    Int Immunopharmacol; 2015 Apr 11; 25(2):425-31. PubMed ID: 25708657
    [Abstract] [Full Text] [Related]

  • 32. No association between IL12B gene polymorphisms and Graves' disease in the Chinese population.
    Liu S, Hou P, Morahan G, Shi B.
    Endocr Res; 2012 Apr 11; 37(4):182-7. PubMed ID: 22621617
    [Abstract] [Full Text] [Related]

  • 33. Genetic susceptibility to Graves' ophthalmopathy: the role of polymorphisms in proinflammatory cytokine genes.
    Anvari M, Khalilzadeh O, Esteghamati A, Esfahani SA, Rashidi A, Etemadi A, Mahmoudi M, Amirzargar AA.
    Eye (Lond); 2010 Jun 11; 24(6):1058-63. PubMed ID: 19798110
    [Abstract] [Full Text] [Related]

  • 34. Lack of association of Graves' disease with the A2 allele of the interleukin-1 receptor antagonist gene in a white European population.
    Mühlberg T, Kirchberger M, Spitzweg C, Herrmann F, Heberling HJ, Heufelder AE.
    Eur J Endocrinol; 1998 Jun 11; 138(6):686-90. PubMed ID: 9678537
    [Abstract] [Full Text] [Related]

  • 35. The A946T polymorphism in the interferon induced helicase gene does not confer susceptibility to Graves' disease in Chinese population.
    Zhao ZF, Cui B, Chen HY, Wang S, Li I, Gu XJ, Qi L, Li XY, Ning G, Zhao YJ.
    Endocrine; 2007 Oct 11; 32(2):143-7. PubMed ID: 18026693
    [Abstract] [Full Text] [Related]

  • 36. Graves' ophthalmopathy and gene polymorphisms in interleukin-1alpha, interleukin-1beta, interleukin-1 receptor and interleukin-1 receptor antagonist.
    Khalilzadeh O, Anvari M, Esteghamati A, Mahmoudi M, Tahvildari M, Rashidi A, Khosravi F, Amirzargar A.
    Clin Exp Ophthalmol; 2009 Aug 11; 37(6):614-9. PubMed ID: 19702713
    [Abstract] [Full Text] [Related]

  • 37. Association studies of the IL-23R gene in autoimmune thyroid disease in the Japanese population.
    Ban Y, Tozaki T, Taniyama M, Nakano Y, Yoneyama K, Ban Y, Hirano T.
    Autoimmunity; 2009 Feb 11; 42(2):126-30. PubMed ID: 19021011
    [Abstract] [Full Text] [Related]

  • 38. beta-2-adrenergic receptor gene polymorphism confers susceptibility to Graves disease.
    Jazdzewski K, Bednarczuk T, Stepnowska M, Liyanarachchi S, Suchecka-Rachon K, Limon J, Narkiewicz K.
    Int J Mol Med; 2007 Jan 11; 19(1):181-6. PubMed ID: 17143563
    [Abstract] [Full Text] [Related]

  • 39. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
    Pawlak-Adamska E, Frydecka I, Bolanowski M, Tomkiewicz A, Jonkisz A, Karabon L, Partyka A, Nowak O, Szalinski M, Daroszewski J.
    Endocrine; 2017 Jan 11; 55(1):186-199. PubMed ID: 27638540
    [Abstract] [Full Text] [Related]

  • 40. Pretibial myxedema is associated with polymorphism in exon 1 of CTLA-4 gene in patients with Graves' ophthalmopathy.
    Khalilzadeh O, Mojazi Amiri H, Tahvildari M, Anvari M, Esteghamati A, Mobarra Z, Tehranchinia Z, Rashidi A, Amirzargar A.
    Arch Dermatol Res; 2009 Oct 11; 301(10):719-23. PubMed ID: 19037649
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.